Combination HBV therapy
TW202626066APending Publication Date: 2026-07-01HUMABS BIOMED SA +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114143284
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2018-12-20
- Filing Date
- 2019-12-19
- Publication Date
- 2026-07-01
Abstract
The present disclosure provides methods for treating HBV infection using combination therapies, and related kits and compositions for use. The components of the combination therapies include an inhibitor of HBV gene expression or an agent that reduces HBV antigenic load, and an anti-HBV antibody.
Need to check novelty before this filing date? Find Prior Art